[시장보고서]경카테터 심장판막 치환 수복 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

경카테터 심장판막 치환 수복 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Transcatheter Heart Valve Replacement Repair Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1539298

리서치사 : Persistence Market Research

발행일 : 2024년 08월

페이지 정보 : 영문 231 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,249,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,587,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,329,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 이번에 세계의 경카테터 심장판막 치환·수복(TAVR) 시장에 관한 상세한 조사 리포트를 출판하고, 촉진요인·동향·기회·과제 등의 시장 역학에 관한 상세 인사이트를 제공했습니다. 특히 심혈관의료기기 업계의 이해관계자용으로 시장 구조와 전망의 종합적 이해를 제공하는 것을 목적으로 하고 있습니다.

주요 인사이트

세계 시장 매출(2022년) : 84억 달러
추정 시장 금액(2033년) : 255억 달러
세계 시장 성장률(CAGR 2022-2033년) : 13.1%

TAVR 세계 시장 - 리포트 범위 :

TAVR 시장은 특히 중증 대동맥판막 협착증 및 기타 심혈관 질환을 앓고 있는 환자의 심장 판막을 교체하거나 수리하는 데 사용되는 장비 및 기술의 생산 및 유통에 중점을 두고 있습니다. 이 시장은 심혈관 질환의 유병률 증가, 최소 침습적 시술의 채택 확대, TAVR 제품의 지속적인 기술 발전에 의해 촉진되고 있습니다.

시장 성장의 촉진요인:

TAVR 제품의 지속적인 기술 발전과 심혈관 질환의 유병률 증가

TAVR 시장의 주요 촉진요인 중 하나는 경피적 대동맥판막 치환술(TAVR) 장비의 지속적인 기술 발전입니다. 업체들은 중증 대동맥판막 협착증 환자의 면역 거부반응을 줄이기 위해 내구성이 강화된 2세대 TAVR 장비를 개발하고 있습니다. 이러한 새로운 장비는 최근 여러 연구에서 입증된 바와 같이 판막 역류, 판막 색전증 및 기타 출혈 사건의 발생률을 낮추는 등 안전성 측면에서 큰 이점을 제공합니다.

고급 영상 기술 또한 TAVR 시술 중 의사결정을 개선하는 데 중요한 역할을 하고 있습니다. 이러한 기술 혁신은 TAVI(경피적 대동맥판막이식술) 및 TAVR 제품의 향후 성장을 가속하는 지속적인 기술 개발을 통해 시장이 번창할 수 있는 유리한 기회를 창출할 것으로 예상됩니다.

심혈관 질환(CVD) 유병률 증가는 TAVR 시장의 성장을 가속하는 또 다른 중요한 요인입니다. 세계보건기구(WHO)에 따르면 심혈관 질환은 전 세계 사망 원인 1위로 연간 1,790만 명이 사망하는 것으로 추산됩니다. 심장마비와 뇌졸중이 CVD로 인한 사망자 5명 중 4명 이상을 차지하는 가운데, TAVR과 같은 효과적인 판막 치환술에 대한 수요가 증가하여 시장 확대의 원동력이 될 것으로 예상됩니다.

시장이 해결해야 할 과제

높은 비용과 규제 문제

유망한 성장 전망에도 불구하고, TAVR 시장은 몇 가지 문제에 직면해 있습니다. 특히 의료 예산이 제한된 중저소득 국가에서 TAVR 시술 및 장비의 높은 비용은 보급에 큰 장벽이 될 수 있습니다. 또한 TAVR 기기의 규제 환경은 복잡하며, 신제품을 시장에 출시하기 전에 엄격한 승인 절차가 필요합니다. 이러한 규제 문제를 극복하는 데는 많은 시간과 비용이 소요되므로 시장 성장이 둔화될 수 있습니다.

또한 기술 발전이 시장을 발전시키는 한편, 연구개발에 대한 막대한 투자도 필요합니다. 기업은 경쟁력을 유지하기 위해 지속적인 기술 혁신을 수행해야 하며, 특히 시장 규모가 작은 기업의 경우 자원을 압박하고 수익성에 영향을 미칠 수 있습니다.

이 보고서에서 다룬 주요 질문

세계 TAVR 시장의 성장을 이끄는 주요 요인은?
TAVR의 채택을 촉진하는 소비자층은?
기술의 발전이 경쟁 구도에 어떤 영향을 미치고 있는가?
세계 TAVR 시장의 주요 기업은 어디이며, 시장 지위를 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 TAVR 시장의 새로운 동향과 전망은?

서론 / 주요 조사 결과
과거 시장 규모(10억 달러) 분석 : 제품별, 2019-2023년
현재 및 향후 시장 규모(10억 달러) 분석과 예측 : 제품별, 2024-2033년
- 경카테터 대동맥판 치환술(TAVR) 디바이스
- 경카테터 승모판 수복(TMVR) 디바이스
시장의 매력 분석 : 제품별

제9장 세계 시장 분석 : 적응증별

서론 / 주요 조사 결과
과거 시장 규모(10억 달러) 분석 : 적응증별, 2019-2023년
현재 및 향후 시장 규모(10억 달러) 분석과 예측 : 적응증별, 2024-2033년
- 중증 대동맥판 협착증
- 밸브 인 밸브 수술(생체 판막 부전)
- 대동맥판 역류증
시장의 매력 분석 : 적응증별

제10장 세계 시장 분석 : 최종사용자별

서론 / 주요 조사 결과
과거 시장 규모(10억 달러) 분석 : 최종사용자별, 2019-2023년
현재 및 향후 시장 규모(10억 달러) 분석과 예측 : 최종사용자별, 2024-2033년
- 병원
- 독립 심장 카테터 검사실
- 외래 수술 센터
시장의 매력 분석 : 최종사용자별

제11장 세계 시장 분석 : 지역별

서론
과거 시장 규모(10억 달러) 분석 : 지역별, 2019-2023년
현재 및 향후 시장 규모(10억 달러) 분석과 예측 : 지역별, 2024-2033년
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카(MEA)
시장의 매력 분석 : 지역별

제12장 북미 시장 분석

제13장 라틴아메리카 시장 분석

제14장 유럽 시장 분석

제15장 동아시아 시장 분석

제16장 남아시아 시장 분석

제17장 오세아니아 시장

제18장 중동 및 아프리카(MEA) 시장 분석

제19장 시장 구조 분석

시장 분석 : 기업 계층별
주요 기업의 시장 점유율 분석
시장 입지 분석

제20장 경쟁 분석

경쟁 대시보드
경쟁 벤치마킹
경쟁 상세 정보
- Abbott
- Edwards Lifesciences Corporation
- Medtronic plc
- Boston Scientific Corporation
- JenaValve Technology, Inc.
- Meril Life Sciences
- Sahajanand Medical Technologies Limited
- MicroPort Scientific Corporation
- Venus Medtech(Hangzhou) Inc.
- Suzhou Jiecheng Medical Technology Co. Ltd.
- Peijia Medical Limited
- Blue Sail Medical Co., Ltd.

제21장 사용되는 전제 조건과 두자어

제22장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently published an in-depth report on the global transcatheter heart valve replacement and repair (TAVR) market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the cardiovascular medical device industry.

Key Insights:

Global Market Revenue (2022): US$ 8.4 Billion
Estimated Market Value (2033): US$ 25.5 Billion
Global Market Growth Rate (CAGR 2022-2033): 13.1%

Global TAVR Market - Report Scope:

The TAVR market focuses on the production and distribution of devices and technologies used in the replacement and repair of heart valves, particularly for patients suffering from severe aortic stenosis and other cardiovascular diseases. This market is driven by the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and continuous technological advancements in TAVR products.

Market Growth Drivers:

Continuous Technological Advancements in TAVR Products Coupled with Increasing Prevalence of Cardiovascular Diseases

One of the primary drivers of the TAVR market is the continuous technological advancements in transcatheter aortic valve replacement (TAVR) devices. Companies are developing second-generation TAVR devices with enhanced durability to reduce immune rejections in patients with severe aortic stenosis. These newer devices offer significant safety benefits, including lower rates of paravalvular regurgitation, valve embolization, and other bleeding events, as evidenced by several recent studies.

Advanced imaging technologies are also playing a crucial role in improving decision-making during TAVR procedures. These innovations are expected to create lucrative opportunities for the market to flourish, with ongoing technological developments driving future growth in TAVI (transcatheter aortic valve implantation) and TAVR products.

The rising prevalence of cardiovascular diseases (CVDs) is another significant factor fueling the growth of the TAVR market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths per year. With heart attacks and strokes making up more than four out of every five CVD deaths, the demand for effective valve replacement surgeries, such as TAVR, is expected to rise, driving market expansion.

Market Challenges:

High Costs and Regulatory Challenges

Despite the promising growth prospects, the TAVR market faces several challenges. The high cost of TAVR procedures and devices can be a significant barrier to widespread adoption, particularly in low- and middle-income countries where healthcare budgets are limited. Additionally, the regulatory landscape for TAVR devices is complex, with stringent approval processes required before new products can be introduced to the market. Navigating these regulatory challenges can be time-consuming and costly, potentially slowing down market growth.

Furthermore, while technological advancements are driving the market forward, they also require substantial investment in research and development. Companies must continuously innovate to stay competitive, which can strain resources and impact profitability, particularly for smaller players in the market.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the global TAVR market?
Which consumer segments are leading the adoption of TAVR procedures?
How are technological advancements influencing the competitive landscape?
Who are the key players in the global TAVR market, and what strategies are they employing to maintain their market position?
What are the emerging trends and future prospects in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market, including Edwards Lifesciences, Medtronic, and Boston Scientific Corporation, are focusing on product innovation, strategic partnerships, and expanding their market presence in emerging economies. These companies are heavily investing in research and development to create next-generation TAVR devices that offer improved safety, durability, and patient outcomes. Collaborations with healthcare providers and academic institutions are enhancing market credibility and driving the adoption of new technologies.

Additionally, the market is seeing a trend towards the integration of advanced imaging and diagnostic tools with TAVR procedures, further improving the precision and outcomes of valve replacement surgeries. As the market continues to grow, companies are expected to explore new opportunities in minimally invasive cardiovascular procedures and expand their product portfolios to cater to a broader patient population.

Key Companies Profiled:

Abbott
Edwards Lifesciences Corporation
Medtronic plc
Boston Scientific Corporation
JenaValve Technology, Inc.
Meril Life Sciences
Sahajanand Medical Technologies Limited
MicroPort Scientific Corporation
Venus Medtech (Hangzhou) Inc.
Suzhou Jiecheng Medical Technology Co. Ltd.
Peijia Medical Limited
Blue Sail Medical Co., Ltd.

Key Segments Covered in Transcatheter Heart Valve Replacement Repair Industry Research

Product:

Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Repair (TMVR)

Indication:

Severe Aortic Valve Stenosis
Valve-in-Valve Procedures (Failed Bioprosthesis)
Aortic Regurgitation

End User:

Hospitals
Independent Cardiac Catheterization Labs
Ambulatory Surgical Centres

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Adoption Rate/Usage Analysis - By Region
4.2. Technology Assessment
4.3. Product USP Analysis
4.4. Regulatory Scenario
4.5. Disease Epidemiology
4.6. Reimbursement Landscape
4.7. Recent Product Approvals/Launches
4.8. PESTEL Analysis
4.9. Porter's Analysis
4.10. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Cardiac Surgery Devices Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Prevalence of Cardiovascular Diseases
- 5.2.2. Demand for Minimally Invasive Procedures
- 5.2.3. Growing Number of Patients Suffering from Aortic Stenosis
- 5.2.4. Increasing Product Approvals
- 5.2.5. Technological Advancements
- 5.2.6. Prevalence of Obesity
- 5.2.7. Increasing Surgical Procedural Volume
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Indication
- 6.1.3. By End User
- 6.1.4. By Region
6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
- 8.3.1. Transcatheter Aortic Valve Replacement (TAVR) Devices
  - 8.3.1.1. Self - Expandable Transcatheter Aortic Valves
  - 8.3.1.2. Balloon-Expandable Transcatheter Aortic Valves
  - 8.3.1.3. "Mechanically Expanded Transcatheter Aortic Valves"
- 8.3.2. Transcatheter Mitral Valve Repair (TMVR) Devices
8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Indication, 2024-2033
- 9.3.1. Severe Aortic Valve Stenosis
- 9.3.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
- 9.3.3. Aortic Regurgitation
9.4. Market Attractiveness Analysis, by Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
- 10.3.1. Hospitals
- 10.3.2. Independent Cardiac Catheterization Labs
- 10.3.3. Ambulatory Surgical Centers
10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Product
- 12.3.3. By Indication
- 12.3.4. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By Indication
- 12.4.4. By End User
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
- 12.7.1. U.S. Market Analysis
  - 12.7.1.1. Introduction
  - 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 12.7.1.2.1. By Product
    - 12.7.1.2.2. By Indication
    - 12.7.1.2.3. By End User
- 12.7.2. Canada Market Analysis
  - 12.7.2.1. Introduction
  - 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 12.7.2.2.1. By Product
    - 12.7.2.2.2. By Indication
    - 12.7.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Product
- 13.3.3. By Indication
- 13.3.4. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Indication
- 13.4.4. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
- 13.7.1. Mexico Market Analysis
  - 13.7.1.1. Introduction
  - 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.7.1.2.1. By Product
    - 13.7.1.2.2. By Indication
    - 13.7.1.2.3. By End User
- 13.7.2. Brazil Market Analysis
  - 13.7.2.1. Introduction
  - 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.7.2.2.1. By Product
    - 13.7.2.2.2. By Indication
    - 13.7.2.2.3. By End User
- 13.7.3. Argentina Market Analysis
  - 13.7.3.1. Introduction
  - 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.7.3.2.1. By Product
    - 13.7.3.2.2. By Indication
    - 13.7.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Product
- 14.3.3. By Indication
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Indication
- 14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
- 14.7.1. Germany Market Analysis
  - 14.7.1.1. Introduction
  - 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.1.2.1. By Product
    - 14.7.1.2.2. By Indication
    - 14.7.1.2.3. By End User
- 14.7.2. Italy Market Analysis
  - 14.7.2.1. Introduction
  - 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.2.2.1. By Product
    - 14.7.2.2.2. By Indication
    - 14.7.2.2.3. By End User
- 14.7.3. France Market Analysis
  - 14.7.3.1. Introduction
  - 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.3.2.1. By Product
    - 14.7.3.2.2. By Indication
    - 14.7.3.2.3. By End User
- 14.7.4. U.K. Market Analysis
  - 14.7.4.1. Introduction
  - 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.4.2.1. By Product
    - 14.7.4.2.2. By Indication
    - 14.7.4.2.3. By End User
- 14.7.5. Spain Market Analysis
  - 14.7.5.1. Introduction
  - 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.5.2.1. By Product
    - 14.7.5.2.2. By Indication
    - 14.7.5.2.3. By End User
- 14.7.6. BENELUX Market Analysis
  - 14.7.6.1. Introduction
  - 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.6.2.1. By Product
    - 14.7.6.2.2. By Indication
    - 14.7.6.2.3. By End User
- 14.7.7. Russia Market Analysis
  - 14.7.7.1. Introduction
  - 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.7.2.1. By Product
    - 14.7.7.2.2. By Indication
    - 14.7.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product
- 15.3.3. By Indication
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Product
- 15.4.2. By Indication
- 15.4.3. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
- 15.7.1. China Market Analysis
  - 15.7.1.1. Introduction
  - 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.1.2.1. By Product
    - 15.7.1.2.2. By Indication
    - 15.7.1.2.3. By End User
- 15.7.2. Japan Market Analysis
  - 15.7.2.1. Introduction
  - 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.2.2.1. By Product
    - 15.7.2.2.2. By Indication
    - 15.7.2.2.3. By End User
- 15.7.3. South Korea Market Analysis
  - 15.7.3.1. Introduction
  - 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.3.2.1. By Product
    - 15.7.3.2.2. By Indication
    - 15.7.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Product
- 16.3.3. By Indication
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Indication
- 16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
- 16.7.1. India Market Analysis
  - 16.7.1.1. Introduction
  - 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.1.2.1. By Product
    - 16.7.1.2.2. By Indication
    - 16.7.1.2.3. By End User
- 16.7.2. Indonesia Market Analysis
  - 16.7.2.1. Introduction
  - 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.2.2.1. By Product
    - 16.7.2.2.2. By Indication
    - 16.7.2.2.3. By End User
- 16.7.3. Malaysia Market Analysis
  - 16.7.3.1. Introduction
  - 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.3.2.1. By Product
    - 16.7.3.2.2. By Indication
    - 16.7.3.2.3. By End User
- 16.7.4. Thailand Market Analysis
  - 16.7.4.1. Introduction
  - 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.4.2.1. By Product
    - 16.7.4.2.2. By Indication
    - 16.7.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Product
- 17.3.3. By Indication
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Indication
- 17.4.4. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. Australia Market Analysis
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.7.1.2.1. By Product
    - 17.7.1.2.2. By Indication
    - 17.7.1.2.3. By End User
- 17.7.2. New Zealand Market Analysis
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.7.2.2.1. By Product
    - 17.7.2.2.2. By Indication
    - 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkiye
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Product
- 18.3.3. By Indication
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Product
- 18.4.2. By Indication
- 18.4.3. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
- 18.7.1. GCC Countries Market Analysis
  - 18.7.1.1. Introduction
  - 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.1.2.1. By Product
    - 18.7.1.2.2. By Indication
    - 18.7.1.2.3. By End User
- 18.7.2. Turkiye Market Analysis
  - 18.7.2.1. Introduction
  - 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.2.2.1. By Product
    - 18.7.2.2.2. By Indication
    - 18.7.2.2.3. By End User
- 18.7.3. South Africa Market Analysis
  - 18.7.3.1. Introduction
  - 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.3.2.1. By Product
    - 18.7.3.2.2. By Indication
    - 18.7.3.2.3. By End User
- 18.7.4. North Africa Market Analysis
  - 18.7.4.1. Introduction
  - 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.4.2.1. By Product
    - 18.7.4.2.2. By Indication
    - 18.7.4.2.3. By End User

19. Market Structure Analysis

19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. Abbott
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Key Financials
  - 20.3.1.5. SWOT Analysis
  - 20.3.1.6. Strategy Overview
    - 20.3.1.6.1. Marketing Strategy
    - 20.3.1.6.2. Product Strategy
    - 20.3.1.6.3. Channel Strategy
- 20.3.2. Edwards Lifesciences Corporation
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Key Financials
  - 20.3.2.5. SWOT Analysis
  - 20.3.2.6. Strategy Overview
    - 20.3.2.6.1. Marketing Strategy
    - 20.3.2.6.2. Product Strategy
    - 20.3.2.6.3. Channel Strategy
- 20.3.3. Medtronic plc
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Key Financials
  - 20.3.3.5. SWOT Analysis
  - 20.3.3.6. Strategy Overview
    - 20.3.3.6.1. Marketing Strategy
    - 20.3.3.6.2. Product Strategy
    - 20.3.3.6.3. Channel Strategy
- 20.3.4. Boston Scientific Corporation
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Key Financials
  - 20.3.4.5. SWOT Analysis
  - 20.3.4.6. Strategy Overview
    - 20.3.4.6.1. Marketing Strategy
    - 20.3.4.6.2. Product Strategy
    - 20.3.4.6.3. Channel Strategy
- 20.3.5. JenaValve Technology, Inc.
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Key Financials
  - 20.3.5.5. SWOT Analysis
  - 20.3.5.6. Strategy Overview
    - 20.3.5.6.1. Marketing Strategy
    - 20.3.5.6.2. Product Strategy
    - 20.3.5.6.3. Channel Strategy
- 20.3.6. Meril Life Sciences
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Key Financials
  - 20.3.6.5. SWOT Analysis
  - 20.3.6.6. Strategy Overview
    - 20.3.6.6.1. Marketing Strategy
    - 20.3.6.6.2. Product Strategy
    - 20.3.6.6.3. Channel Strategy
- 20.3.7. Sahajanand Medical Technologies Limited
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Key Financials
  - 20.3.7.5. SWOT Analysis
  - 20.3.7.6. Strategy Overview
    - 20.3.7.6.1. Marketing Strategy
    - 20.3.7.6.2. Product Strategy
    - 20.3.7.6.3. Channel Strategy
- 20.3.8. MicroPort Scientific Corporation
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Key Financials
  - 20.3.8.5. SWOT Analysis
  - 20.3.8.6. Strategy Overview
    - 20.3.8.6.1. Marketing Strategy
    - 20.3.8.6.2. Product Strategy
    - 20.3.8.6.3. Channel Strategy
- 20.3.9. Venus Medtech (Hangzhou) Inc.
  - 20.3.9.1. Overview
  - 20.3.9.2. Product Portfolio
  - 20.3.9.3. Sales Footprint
  - 20.3.9.4. Key Financials
  - 20.3.9.5. SWOT Analysis
  - 20.3.9.6. Strategy Overview
    - 20.3.9.6.1. Marketing Strategy
    - 20.3.9.6.2. Product Strategy
    - 20.3.9.6.3. Channel Strategy
- 20.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
  - 20.3.10.1. Overview
  - 20.3.10.2. Product Portfolio
  - 20.3.10.3. Sales Footprint
  - 20.3.10.4. Key Financials
  - 20.3.10.5. SWOT Analysis
  - 20.3.10.6. Strategy Overview
    - 20.3.10.6.1. Marketing Strategy
    - 20.3.10.6.2. Product Strategy
    - 20.3.10.6.3. Channel Strategy
- 20.3.11. Peijia Medical Limited
  - 20.3.11.1. Overview
  - 20.3.11.2. Product Portfolio
  - 20.3.11.3. Sales Footprint
  - 20.3.11.4. Key Financials
  - 20.3.11.5. SWOT Analysis
  - 20.3.11.6. Strategy Overview
    - 20.3.11.6.1. Marketing Strategy
    - 20.3.11.6.2. Product Strategy
    - 20.3.11.6.3. Channel Strategy
- 20.3.12. Blue Sail Medical Co., Ltd.
  - 20.3.12.1. Overview
  - 20.3.12.2. Product Portfolio
  - 20.3.12.3. Sales Footprint
  - 20.3.12.4. Key Financials
  - 20.3.12.5. SWOT Analysis
  - 20.3.12.6. Strategy Overview
    - 20.3.12.6.1. Marketing Strategy
    - 20.3.12.6.2. Product Strategy
    - 20.3.12.6.3. Channel Strategy